http://www.fpnotebook.com/
Adult VaccinationAka: Adult Immunization, Immunization
- See Also
- Protocol: Age 18 to 60 years (or 65)
- Influenza Vaccine
- Offer annual vaccination in all patients and especially high risk groups
- Tetanus Vaccine
- Consider Tdap (Adacel)
- HPV Vaccine (Gardasil)
- Women under age 26 years
- Influenza Vaccine
- Protocol: Age 60 years (or 65) and older
- Influenza Vaccine
- Annual vaccination in all patients
- Tetanus Vaccine
- Repeat every 5-10 years
- Consider giving at hospital discharge
- Pneumococcal Vaccine (Pneumovax)
- One dose (unless other indications such as Asplenic)
- Consider giving at hospital discharge
- Zoster Vaccine
- Give one dose
- Influenza Vaccine
Vaccines (C0042210) | |
|---|---|
| Definition (MSH) | Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa, or rickettsiae), antigenic proteins derived from them, or synthetic constructs, administered for the prevention, amelioration, or treatment of infectious and other diseases. |
| Definition (CSP) | prophylactic or therapeutic preparation given to produce immune response to pathogenic organisms or substances; vaccines are used not only in infectious disease prevention and treatment, but in neoplastic and autoimmune disease treatment, control of fertility, drug abuse control etc. |
| Definition (NCI) | A substance or group of substances meant to cause the immune system to respond to a tumor or to microorganisms, such as bacteria or viruses. A vaccine can help the body recognize and destroy cancer cells or microorganisms. |
| Definition (NCI) | Preparations containing substances with antigenic properties administered to activate the immune system, inducing an immune response. Vaccine ranges from inactivated or attenuated microorganisms (bacteria and viruses), enhanced autologous tumor cells, tumor antigens or epitopes, to peptide cojugated immunotoxins that are used to elicit host immune responses. Vaccines are used for the prevention, amelioration, or treatment of infectious diseases and cancer. |
| Concepts | Pharmacologic Substance (T121) , Immunologic Factor (T129) |
| MSH | D014612 |
| English | vaccine, Vaccines |
| Spanish | vacuna |
| Parent Concepts | Biological Products (C0005522), Immunologic Factors (C0021054), Biological Response Modifiers (C0005525), Immunotherapeutic agent (C0876248), Vaccine, immunoglobulins and antisera (C0360485), Vaccine, immunoglobulin, AND/OR antiserum (C1630493), IMMUNE STIMULANTS (C1579313) |
| Sources | AOD, CSP, LCH, LNC, MSH, MTH, NCI, NDFRT, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
Adult Immunization (C1456566) | |
|---|---|
| Concepts | Therapeutic or Preventive Procedure (T061) |
| English | Adult Immunization |
| Sources | MEDLINEPLUS Derived from the NIH UMLS (Unified Medical Language System) |
